# Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients

> **NCT02686710** · PHASE4 · TERMINATED · sponsor: **Moscow Regional Research and Clinical Institute (MONIKI)** · enrollment: 10 (actual)

## Conditions studied

- Glycogen Synthase Kinase 3

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT02686710
- **Lead sponsor:** Moscow Regional Research and Clinical Institute (MONIKI)
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686710, "Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02686710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*